New research led by Burnet Institute utilises novel virus-like particles for malaria vaccine development
11 September 2019 New research led by Burnet Institute has demonstrated the effective use of a novel virus-like particles (VLPs) platform for malaria vaccines. The study, published in the international journal PLOS ONE, utilised a novel technology co-developed…
Medtronic Launches New Way to Stimulate Medical Technology Innovation in ANZ
11 September 2019 Medtronic seeks partnership with innovating physicians in Australia and New Zealand to improve healthcare. Sydney, Australia – 11 September 2019 – Medtronic Australasia today launched Medtronic Eureka, a web-based portal for medical technology innovation designed…
Opthea Presents Positive Data from Wet AMD Trial at EURETINA
6 September 2019 Melbourne, Australia; – Opthea Limited (ASX:OPT), a clinical biopharmaceutical company developing novel biologic therapies for eye diseases, announced today that new clinical data from its completed 366 patient Phase 2b randomised, controlled study of OPT-302…
The Social Costs of Delaying Effective Cancer Treatment Using CAR-T Immunotherapy
5 September 2019 CAR-T therapy can save lives and boost benefits to society … if it’s delivered promptly, says Cartherics CEO and Executive Director, Alan Trounson Using the tools of biotechnology and immunology to help transforming cancer from…
Companies urged to help with information on RDTI
3 September 2019 AusBiotech is commissioning research to quantify the additionality and spill-over effects of the R&D Tax Incentive (RDTI) and urgently calls on companies to help with information. Full article here.
Australia’s National Digital Health Survey is open!
3 September 2019 Together we can transform the digital health sector in Australia; simply click the button below As Australia’s only dedicated provider of digital health commercialisation support, ANDHealth is seeking input from digital health innovators and companies…
GTG New Board Appointment
2 September 2019 Genetic Technologies is pleased to announce the appointment of Nick Burrows as Non-Executive Director to the board. Mr Burrows is a contemporary independent Non-Executive Director across the Listed, Government and Private sectors with significant expertise…
FDA provides guidance on clinical pathway to marketing application for Revascor in end-stage heart failure patients with an LVAD
Melbourne Australia; 27 August 2019, and New York, USA, 26 August 2019 Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in cellular medicines for inflammatory diseases, announced today positive outcomes from its recent meeting with the United States Food and…
IDT Secures its first Medicinal Cannabis Manufacturing Permit from the Office of Drug Control
27 August 2019 IDT Australia Limited (ASX: IDT) is pleased to announce that the Department of Health – Office of Drug Control has granted the Company its first Medicinal Cannabis Manufacturing Permit under the Narcotic Drugs Act 1967.…
Positive results with Targeted DEP® using antibody fragment in human ovarian cancer model – Starpharma
29 August 2019 Melbourne, Australia: Starpharma today announced that treatment with a novel HER-2 Targeted DEP® conjugate from its internal Targeted DEP® program resulted in tumour regression and 100% survival in a preclinical human ovarian cancer model. This finding builds on…
Next step in Alzheimer’s disease treatment – SVI & Janssen Pharmaceucticals Inc
29 August 2019 SVI has announced the extension of the research and licensing collaboration agreement with Janssen Pharmaceuticals, Inc, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, with focus on Alzheimer’s disease treatment. The objective of…
The Australian PBS approves Mayne Pharma’s Kapanol morphine drug for reimbursement
29 August 2019 Mayne Pharma says the Australian Pharmaceutical Benefits Scheme has approved its Kapanol morphine drug for palliative care chronic breathlessness for reimbursement. Mayne Pharma said that from September 1, 2019 eligible palliative care patients taking 10mg…
